LibiGel is being developed to treat female sexual dysfunction (FSD), hypoactive sexual desire disorder (HSDD) in menopausal women to be specific, for which there is no FDA approved
The network is intended to generate positive synergies for the company and home-based billers and create a win-win situation for both. The home-based biller would represent Med DataCare
Currently, only those who are 17 and older can buy it without a doctor’s order, Reuters.com reported. Initially approved in 1999, Plan B contains a higher dose of
Children’s Hospital Division of Endocrinology physician and researcher Umut Ozcan has demonstrated that the regulatory protein XBP-1s, when activated artificially in the liver, can normalize high blood sugar
The collaboration came in line with EEC’s special attention to the pharmaceutical sector primarily because of the quality of jobs they will create and the products they will
RISE is a multicenter, randomized, double-masked, sham injection-controlled, 36-month Phase III study designed to assess the safety and efficacy profile of Lucentis in 377 patients with DME. The
TIBCO will now incorporate General Dynamics’ ViPS’ NAV-10 technology into its selected Foresight products. The NAV-10 Code Translation Suite is an integral part of the General Dynamics’ ICD-10
Inhibitex is developing a series of proprietary nucleotide inhibitors that target the RNA-dependent RNA polymerase (NS5b) of HCV. INX-189 is a protide of a 2′-C-methylguanosine analogue. Inhibitex believes
The FlexTab technology allows for a variety of fill materials, including powders, pellets, liquids, micro-tablets and tablets, and can even deliver separate liquid and powder active pharma ingredients
Axcan Pharma has completed the previously announced tender offer for the outstanding ordinary shares of Eurand for $587m. Axcan president and CEO Frank Verwiel said the combination of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.